[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@fwpharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::35789155.png) @fwpharma FirstWord Pharma

FirstWord Pharma posts on X about $mrk, $pfe, $lly, regeneron the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::35789155/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35789155/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +20%

### Mentions: XX [#](/creator/twitter::35789155/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35789155/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX +0.91%
- X Year XXXXX +28%

### Followers: XXXXXX [#](/creator/twitter::35789155/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35789155/c:line/m:followers.svg)

- X Week XXXXXX -XXXX%
- X Month XXXXXX -XXXX%
- X Months XXXXXX +0.05%
- X Year XXXXXX -XXXX%

### CreatorRank: XXXXXXX [#](/creator/twitter::35789155/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35789155/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX% [currencies](/list/currencies)  XXX%

**Social topic influence**
[$mrk](/topic/$mrk) #60, [$pfe](/topic/$pfe) #112, [$lly](/topic/$lly) #128, [regeneron](/topic/regeneron) #18, [$regn](/topic/$regn) #21, [$azn](/topic/$azn) #8, [$rhhby](/topic/$rhhby) #2, [$rgnx](/topic/$rgnx) #7, [$gild](/topic/$gild) 1.85%, [$aclx](/topic/$aclx) XXXX%

**Top accounts mentioned or mentioned by**
[@wolterskluwers](/creator/undefined) [@mcflusion](/creator/undefined)

**Top assets mentioned**
[Merck & Co., Inc. (MRK)](/topic/$mrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Eli Lilly and Company (LLY)](/topic/$lly) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [AstraZeneca PLC (AZN)](/topic/$azn) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Synthetify (SNY)](/topic/$sny) [Frontline Ltd. (FRO)](/topic/$fro) [Amgen, Inc. (AMGN)](/topic/$amgn) [Halozyme Therapeutics, Inc. (HALO)](/topic/$halo) [Novartis AG (NVS)](/topic/novartis) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy)
### Top Social Posts
Top posts by engagements in the last XX hours

"Anito-cel keeps its neurotox profile clean MM survival rates high after two years #ASH25 $GILD $ACLX"  
[X Link](https://x.com/fwpharma/status/1997974955091239351)  2025-12-08T10:22Z 55.1K followers, 1133 engagements


"Alkermes posts another mid-stage success for orexin drug in narcolepsy $ALKS"  
[X Link](https://x.com/fwpharma/status/1988614218665328864)  2025-11-12T14:25Z 55.1K followers, XXX engagements


"Nuvalent lung cancer readout sets up possible duel with Pfizer's Lorbrena $NUVL $PFE"  
[X Link](https://x.com/fwpharma/status/1990544162681467133)  2025-11-17T22:14Z 55.1K followers, XXX engagements


"FDA pushes back decision on Ascendis' achondroplasia drug to February $ASND"  
[X Link](https://x.com/fwpharma/status/1993628970554958209)  2025-11-26T10:32Z 55.1K followers, XXX engagements


"Early stop for efficacy in Praxis' registrational study of relutrigine for rare childhood epilepsies $PRAX"  
[X Link](https://x.com/fwpharma/status/1996885124978462865)  2025-12-05T10:11Z 55.1K followers, XXX engagements


"Pfizer backs $100M round for Chinese biotech's R&D hub model $PFE"  
[X Link](https://x.com/fwpharma/status/1997044828874621315)  2025-12-05T20:46Z 55.1K followers, XXX engagements


"BREAKING NEWS: Merck & Co. to acquire Cidara for $9.2B gaining late-stage antiviral $MRK $CDTX"  
[X Link](https://x.com/fwpharma/status/1989302262909292753)  2025-11-14T11:59Z 55.1K followers, XXX engagements


"CHMP roundup: Merck & Co.'s newly acquired Verona pulls EU filing for COPD drug $MRK $IONS $LLY $SNY $AVXL"  
[X Link](https://x.com/fwpharma/status/1989461949844013401)  2025-11-14T22:34Z 55.1K followers, XXX engagements


"Merck & Co.'s HIV tablet matches Biktarvy in treatment-nave patients $MRK"  
[X Link](https://x.com/fwpharma/status/1991271139596030082)  2025-11-19T22:23Z 55.1K followers, XXX engagements


"Kelun-Biotech touts front-line lung cancer win for ADC partnered with Merck & Co. $MRK"  
[X Link](https://x.com/fwpharma/status/1993256973484409344)  2025-11-25T09:54Z 55.1K followers, XXX engagements


"Lilly Direct to offer lower-priced single-dose Zepbound vials $LLY"  
[X Link](https://x.com/fwpharma/status/1995607971972481164)  2025-12-01T21:36Z 55.1K followers, XXX engagements


"Regeneron bets $275M on Tessera's AATD gene-writing fix $REGN"  
[X Link](https://x.com/fwpharma/status/1995575074343321992)  2025-12-01T19:25Z 55.1K followers, XXX engagements


"Generate:Biomedicines' AI-engineered TSLP antibody headed to Phase III $AMGN $AZN"  
[X Link](https://x.com/fwpharma/status/1995575287883673835)  2025-12-01T19:26Z 55.1K followers, XXX engagements


"Daiichi escapes Enhertu royalties as appeals court tosses Seagen ADC patent claims $DSNKY $PFE"  
[X Link](https://x.com/fwpharma/status/1996335035658764521)  2025-12-03T21:45Z 55.1K followers, XXX engagements


"Pfizer Regeneron back TRIANA's $120M raise to advance lead molecular glue $PFE $REGN"  
[X Link](https://x.com/fwpharma/status/1996335210246676971)  2025-12-03T21:46Z 55.1K followers, XXX engagements


"German court blocks Merck & Co.'s Keytruda SC amid patent clash $MRK $HALO"  
[X Link](https://x.com/fwpharma/status/1997032743218434071)  2025-12-05T19:58Z 55.1K followers, XXX engagements


"Peer-reviewed content isnt just trustworthy it drives better marketing outcomes. @Wolters_Kluwer's latest guide reveals how combining peer-reviewed content with strategic distribution can influence prescribing decisions and deliver measurable ROI. Inside the guide youll learn: Actionable techniques to inspire physician action How to integrate peer-reviewed platforms into your campaigns Data-driven insights to improve outreach performance Take your HCP marketing to the next level with the power of trusted content. Download the guide today: #contentmarketing #digitalengagement #HCPs"  
[X Link](https://x.com/fwpharma/status/1993337473200492636)  2025-11-25T15:14Z 55.1K followers, XXX engagements


"Novartis partners with Relation to discover new targets for atopic diseases $NVS"  
[X Link](https://x.com/fwpharma/status/1998346614071578929)  2025-12-09T10:58Z 55.1K followers, XXX engagements


"Roche wins EU approval for Gazyvaro in lupus nephritis $RHHBY"  
[X Link](https://x.com/fwpharma/status/1998466969872298253)  2025-12-09T18:57Z 55.1K followers, XXX engagements


"Excelsior raises $95M for AI 'smart bloccs' that can boost drug discovery manufacturing"  
[X Link](https://x.com/fwpharma/status/1996335391738138835)  2025-12-03T21:47Z 55.1K followers, XXX engagements


"CervoMed on cusp of pivotal trial for dementia drug after tumultuous year $CRVO #CTAD25"  
[X Link](https://x.com/fwpharma/status/1996855400206102945)  2025-12-05T08:13Z 55.1K followers, XXX engagements


"Lilly presents case for earlier use of Jaypirca after topping Imbruvica in key study #ASH25 $LLY"  
[X Link](https://x.com/fwpharma/status/1997975074410778816)  2025-12-08T10:22Z 55.1K followers, XXX engagements


"Atopic dermatitis data bolster Kymera's hopes of matching Dupixent's efficacy with oral STAT6 degrader $KYMR"  
[X Link](https://x.com/fwpharma/status/1998023354775994627)  2025-12-08T13:34Z 55.1K followers, XXX engagements


"FDA extends review of Regenxbio's MPS II gene therapy to assess longer-term data $RGNX"  
[X Link](https://x.com/fwpharma/status/1957759030971052113)  2025-08-19T10:58Z 55.1K followers, XXX engagements


"Regenxbio touts long-term MPS II gene therapy data after FDA extends review $RGNX"  
[X Link](https://x.com/fwpharma/status/1964777285623628080)  2025-09-07T19:46Z 55.1K followers, XXX engagements


"Alnylam raises bar again as Amvuttra keeps beating expectations $ALNY"  
[X Link](https://x.com/fwpharma/status/1983949851688890575)  2025-10-30T17:31Z 55.1K followers, XXX engagements


"Junevity adds $10M to seed round after unveiling lead siRNA for obesity diabetes"  
[X Link](https://x.com/fwpharma/status/1996351059066040717)  2025-12-03T22:49Z 55.1K followers, XXX engagements


"Early findings for AstraZeneca's dual-targeted CAR-T show XXX% ORR in MM #ASH25 $AZN"  
[X Link](https://x.com/fwpharma/status/1997974707677610118)  2025-12-08T10:21Z 55.1K followers, 4693 engagements


"BioNTech BMS flex upbeat interim mid-stage data for PD-L1/VEGF-A in TNBC #SABCS25 $BMY $BNTX"  
[X Link](https://x.com/fwpharma/status/1998374368938951006)  2025-12-09T12:49Z 55.1K followers, 1001 engagements


"Liver signals again trigger partial FDA hold on Roche's fenebrutinib MS studies $RHHBY"  
[X Link](https://x.com/fwpharma/status/1998467327407313276)  2025-12-09T18:58Z 55.1K followers, XXX engagements